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Abstract
Background: The objective of this study was to estimate the burden of disease and injury in Iran
for the year 2003, using Disability-Adjusted Life Years (DALYs) at the national level and for six
selected provinces.
Methods: Methods developed by the World Health Organization for National Burden of Disease
(NBD) studies were applied to estimate disease and injury incidence for the calculation of Years of
Life Lost due to premature mortality (YLL), Years Lived with Disability (YLD), and DALYs. The
following adjustments of the NBD methodology were made in this study: a revised list with 213
disease and injury causes, development of new and more specific disease modeling templates for
cancers and injuries, and adjustment for dependent comorbidity. We compared the results with
World Health Organization (WHO) estimates for Eastern Mediterranean Region, sub-region B in
2002.
Results: We estimated that in the year 2003, there were 21,572 DALYs due to all diseases and
injuries per 100,000 Iranian people of all ages and both sexes. From this total number of DALYs,
62% were due to disability premature deaths (YLD) and 38% were due to premature deaths (YLL);
58% were due to noncommunicable diseases, 28% – to injuries, and 14% – to communicable,
maternal, perinatal, and nutritional conditions. Fifty-three percent of the total number of 14.349
million DALYs in Iran were in males, with 36.5% of the total due to intentional and unintentional
injuries, 15% due to mental and behavioral disorders, and 10% due to circulatory system diseases;
and 47% of DALYs were in females, with 18% of the total due to mental and behavioral disorders,
18% due to intentional and unintentional injuries, and 12% due to circulatory system diseases. The
disease and injury causes leading to the highest number of DALYs in males were road traffic
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accidents (1.071 million), natural disasters (548 thousand), opioid use (510 thousand), and ischemic
heart disease (434 thousand). The leading causes of DALYs in females were ischemic heart disease
(438 thousand), major depressive disorder (420 thousand), natural disasters (419 thousand), and
road traffic accidents (235 thousand). The burden of disease at the province level showed marked
variability. DALY estimates by Iran's NBD study were higher than those for EMR-B by WHO.
Conclusion: The health and disease profile in Iran has made the transition from the dominance of
communicable diseases to that of noncommunicable diseases and road traffic injuries. NBD results
are to be used in health program planning, research, and resource allocation and generation policies
and practices.
Background
This paper presents the main findings of the first National
Burden of Disease (NBD) study in Iran, which was con-
ducted for the year 2003 by the Health Programs Manage-
ment Bureau of the Ministry of Health and Medical
Education (MOHME) in collaboration with other depart-
ments of the Health Deputy of MOHME and Universities
of Medical Sciences, with the support of the Eastern Med-
iterranean Regional Office (EMRO) of the World Health
Organization (WHO), and senior consultancy by Profes-
sor Alan D. Lopez, Head of the School of Population
Health at the University Queensland. We adopted the
methodology described by WHO for conducting NBD
studies to calculate Years of Life Lost due to premature
mortality (YLL), Years Lived with Disability (YLD), and
Disability-Adjusted Life Years (DALYs) for more than 200
disease and injury causes and 27 risk factors, as well as
Health-Adjusted Life Expectancy (HALE), for the year
2003 [1]. DALYs were estimated at the national level as
well as for six selected provinces individually. The results
of healthy life expectancy and burden of risk factors esti-
mation are presented elsewhere.
The history of the first Iranian National Burden of Dis-
ease, Risk Factors, and Healthy Life Expectancy (IRNBD)
study goes back to a preliminary study of the burden of
disease (BOD) in three provinces in 2002. The literature
on burden of disease and other countries' experiences
with national burden of disease studies, as well as the dia-
logue and advocacy about BOD in scientific and policy
circles in Iran, resulted in the inclusion of these results in
health policy making, as reflected in the "Law of the
Fourth Economic, Social, and Cultural Development Plan
of the Islamic Republic of Iran" [2]. Using the available
human resources and data, and developing other neces-
sary capacities, the National Burden of Disease Study in
Iran began in 2003 and continued until late 2005. The
study's team included more than fifty epidemiologists,
demographers, and social medicine and clinical special-
ists, as well as more than ten collaborating research cent-
ers and organizations. The study's methodology, protocol,
and results were published in Farsi and shared with stake-
holders through presentations and publications [3].
Summary Measures of Population Health (SMPH) that
describe health gaps and health expectancies reflect the
attempt to measure health and make WHO's definition of
health which was introduced in the 40 s operationally
measurable and comparable in a global context. As popu-
lations go through the demographic, epidemiologic, and
health transitions, conventional mortality measures pro-
gressively fail to fully reflect the quantity of ill health and
its impact on population health. One major cause for this
is the shift of populations' disease profile from the domi-
nance of communicable, maternal, perinatal, and nutri-
tional conditions to noncommunicable diseases, which
lead to more non-fatal health outcomes as compared with
their contribution to mortality. New Summary National
Burden of Disease studies, which describe the level of
population health with HALE, and the burden of disease
with DALYs form part of a broader framework that aims at
Health System Performance Assessment (HSPA) [4]. In
addition to the level of population health (HALE) and
health problems (DALYs), the equity in the distribution of
population heath has been estimated in the HSPA frame-
work for Iran in a collaborative study by MOHME, WHO,
and the Epidemiology and Biostatistics Department,
School of Public Health, Tehran University of Medical Sci-
ences [5].
The overall objective of the first National Burden of Dis-
ease Study in Iran was to provide quantitative estimations
of the burden of death and disability, their determinants,
and the average level of population health. The ultimate
goal of the study was to provide evidence to inform health
policy making, in order to guide priorities in health inter-
vention program planning, health and biomedical
research, and resource generation and expansion.
Methods
We used the NBD methodology recommended by WHO
to compute years of life lost due to premature mortality
(YLL), years lived with disability (YLD), and disability-
adjusted life years (DALYs); the GBD 1990 values of C =
0.1658 and β = 0.04 were used for standard age weighting,
and a discount rate of R = 0.03 – for health gain in the
future. C is an adjustment constant that ensures the equal-Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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ity of total burden in the GBD 1990 with and without age
weighting, β determines the importance of age weights,
and R discount rate adjusts for health gains or losses in the
future [1]. Similar methods were used to estimate the dis-
ease burden for six provinces separately (Hormozgan, East
Azerbaijan, Khorasan, Bushehr, Yazd, and Charmahal &
Bakhtiary). These provinces were selected based on their
prior capacities for organizational change within the con-
text of the Health Sector Reform project funded by the
World Bank and commissioned by the World Health
Organization, and also on their various geographical loca-
tions in Iran with different levels of socioeconomic and
health development. Data sources and adjustments to the
NBD methods are described below. Specific departures
from the GBD methodology are presented first, i.e. cause
list expansion, cancer burden estimation, comorbidity
adjustment for injuries, disability weights derivation, and
development of BOD management software.
Choosing the diseases
We modified the GBD list of diseases, taking into consid-
eration Iran's epidemiological circumstances for inclusion
and exclusion of detailed disease causes. For instance,
more than ten diseases (like yellow fever and trypano-
somiasis) that do not exist in Iran were excluded and a few
diseases of epidemiological or social importance in the
country (e.g. thalassemia and brucellosis) were added to
the list. The list was finally ordered by ICD-10 codes [6].
Systematic discussion with health policy makers, high-
level managers, researchers, and clinical specialists
ensured that no disease or injury cause with epidemiolog-
ical, economic, social, political, or clinical importance at
the population level was missed from the list. The detailed
list of causes selected for the IRNBD is provided in the
Additional file 1.
Disease-specific modeling templates
Cancers and injuries were modeled with disease-specific
templates (described below). Three other disease groups,
namely perinatal and maternal conditions, and congeni-
tal malformations and chromosomal abnormalities were
also modeled without using the DISMOD software. Most
of the perinatal conditions, congenital malformations
and chromosomal abnormalities manifest at birth and
need early treatment or correction. They lead to high mor-
tality or lifetime disabilities and do not occur during any
other period of life. Maternal conditions have similar
characteristics and only occur during pregnancy or shortly
after delivery. In fact, the dominant measure of their fre-
quency is incidence, whereas it is reasonable to use preva-
lence to measure their long-term complications.
Cancer
Given the incompleteness of cancer survival information,
the model described by Mathers et al. [7] was used to
model the cancer survival and complete the parameters
needed for the epidemiological modeling of cancer and
assessing their internal consistency, using the cancer regis-
try and death registry information. A specific disease mod-
eling template software, called "CANMOD", was
developed for cancers, based on specific mortality rates
from both the cancer and death registries in 2003, as well
as on other sources of national and international informa-
tion on cancer prevalence, incidence, and survival. This
disease-specific template set the internal consistency for
information from the above two sources of mortality rates
along with cancer survival rates. Incidence and survival
rates for cancer patients were obtained using the age-spe-
cific incidence rates estimated based on survival and mor-
tality rates from the cancer registry. The obtained
incidence rates were used for the calculation of incidence-
to-mortality ratios. If these ratios were not compatible
with rates deemed plausible for Iran's setting, the survival
rates were gradually changed to reach such plausibility.
Survival information was fitted to a Weibull distribution
for all ages. Using the available data, the proportions of
patients entering each possible state in the natural history
of different types of cancers were calculated (i.e. A1. Diag-
nosed and under treatment, A21. Controlled, A22.
Treated premetatstatic, B1. Untreated premetatstatic, B2.
Metastatic, B3. Terminal). Then using the incidence rate,
the number of patients entering each state was obtained.
Using the average duration and disability weight of each
state, YLDs were calculated for all states and the results
summed up for that specific cancer. For assessing the
internal validity of the model for each cancer, the inci-
dence rate obtained from the model was checked against
the incidence rate from the cancer registry. Given the
higher coverage of the death registry as compared with the
cancer registry, the model was valid if the model-based
incidence was higher than the cancer registry-based inci-
dence. The resulting burden was also compared with the
burden estimated for EMR-B and the GBD for assessing
the external validity of estimates.
Injuries
A specific model was developed for calculating the disabil-
ity weight of multiple trauma patients. Individual-level
data for 13,400 hospitalized trauma patients from twelve
provinces studied in July to October 2003, covering a pop-
ulation of 9.6 million [8] were used to calculate the YLL
and YLD, along with the disability weight taking into
account the comorbidity. Disability durations and
weights were adopted from the GBD and Victorian BOD
studies [9,10]. In patients who suffered an accident and in
fact the "coincidence" of multiple simultaneous injuries,
comorbid disability weights were calculated through the
following steps for each individual: (A) the injuries were
rank ordered according to their ascending value of dura-
tion; (B) a "common disability weight" for i coincidentPopulation Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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injuries was calculated using the following formula,
which is the general formula for the multiplicative model:
where DW1 through DWi are the disability weights for the
longest through shortest duration injuries; (C) then for
the time interval in which the injury of shortest duration
had healed but the other two continued to coexist,
another common disability weight was calculated as:
The above two formulae are adopted from the formulae
used for correction for independent comorbidity between
major condition groups in calculation of prevalence-
based YLD [1,4]. (D) And for the last time interval in
which only the longest duration injury continued to exist,
only the disability weight of this injury, "Common DW
(1,1)" = DW (1), was taken into account. In situations where
more than three injuries had occurred at the same time, a
similar calculation method was used. (E) Eventually, the
time interval with three coexistent injuries was multiplied
by "Common DW (1,3)," the time interval with two con-
current injuries was multiplied by "Common DW (1,2),"
the last time interval with only the injury with the longest
duration was multiplied by "Common DW (1,1)" = DW (1),
and YLD was summed for the whole time interval with
multiple injuries. The maximum number of comorbid
disabilities in this template was five, since patients with
six or more concurrent disabilities were extremely rare.
Accidents and injuries not leading to hospitalization but
resulting in emergency department care or outpatient
services were included. Only the trivial injuries managed
by the injured persons without receiving any healthcare
services were not included. We assumed that the YLD rates
for multiple trauma derived from this sample of 13,400
patients from twelve provinces studied for four months of
the year 2003 were generalizable to the whole population
of Iran in that year, since the variability of these YLD rates
should have been low during the year and across all prov-
inces.
Disability weights
Disability weights for disease and injury causes in the
GBD list [9] were adopted. For other disease and injury
causes in our list but not in the GBD list, weights were
adopted from the Dutch Disability Weights Group [11].
For 86 causes in our list and not in either the GBD or the
Dutch list, we used a Delphi method for obtaining the dis-
ability weights through specialists' opinion [12]. The list
of these causes, along with the GBD and Dutch lists of
causes (without the disability weights) was given to a
number of relevant clinical specialists (members of the
specialty and subspecialty national boards). The special-
ists were asked to identify those causes in the GBD and
Dutch lists, to which the disability profile of each of the
above-mentioned 86 causes was most similar. The most
frequent responses were extracted. The specialists were
then asked about the disability weight that they would
assign for each cause, given the summary results of the
first round, and the average weights were drawn. Finally,
the list of 86 causes and their mean given disability
weights was presented to the respondents for the finaliza-
tion of the disability weights, taking into consideration
the average weights, their own individual responses, and
their clinical judgment about the similarity of disability
profiles. Furthermore, the respondents were asked to
identify any sex and age differences in weights, if applica-
ble. Disability weights for all causes in the GBD and
IRNBD studies are provided [see Additional file 2].
Burden of disease management software
There were 213 disease and injury causes for which epide-
miological disease modeling was performed, each of these
causes had more than five spreadsheet files on average,
and there were many other spreadsheet files based on
templates for YLL and DALY calculations. Thus, a "Burden
of Disease Management" software using Access and Excel
was developed to contain, relate, and manage all the input
data, intermediate calculations, and output results for
DALY estimation. This software also contained the preva-
lence-based YLD estimation sheets, which were used for
the estimation of healthy life expectancy.
Population estimation
The population of Iran in 2003 was estimated by age
group and sex (using the last census from 1996). The fol-
lowing formula was used for estimating the population at
age x in each sex separately:
in which P(x+1, t+1) is population at age (x+1) in one year
after the reference year, P(x, t) is population at age x in year
t or the reference year, Sx is the survival probability from
age x to (x+1), Ix is the number of immigrants of age x, and
Ox is the number of emigrants of age x. The baseline pop-
ulation for age zero was the number of births in year t. The
age-specific fertility rates were multiplied by the popula-
tion of women between the time intervals 1996–2001 and
2001–2006, and then multiplied by a proportion of 0.488
to obtain the number of female births and by 0.512 to
obtain the number of male births. The population in five-
year groups (starting from 0–4 years) was estimated using
the survival probabilities from birth to six months or to
2.5 years and in a similar way for n-year age groups. In this
way, populations of all age-sex groups were estimated for
the reference year 2003.
Common DW DW (,) ( ) 11 1 ii
i
=− − ∏
Common DW DW DW DW (,) (( ) * ) 12 1 1 2 1 =+ −
PP S I O xt x t x x x (, ) ( , ) [* ] ++=+ − 11Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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Mortality and YLL
For the estimation of mortality rates and YLL, data from
the national death registry of MOHME [13] were used and
garbage codes were redistributed. The death registration
system of Iran's MOHME covered four provinces in 1999,
and 23 out of Iran's 28 provinces in 2003 with a popula-
tion of 48,379,552 (i.e. 73% of the national population of
66,518,224). Deaths and population data from these 23
provinces were used for the estimation of mortality rates,
YLL, and also total life expectancy and healthy life expect-
ancy. The system extended its coverage to 29 out of 30
provinces in 2005, and full national coverage will be
achieved in 2008. Iran's death registration system has
been described as "a good example" of "a system of death
registration with medical information on the cause of
death" [14], developed in recent years in order to capture
the necessary mortality data, following the publication of
the initial results of the GBD study. For Iran, District
Health "Networks" deliver inpatient and outpatient
health care in governmental hospitals and outpatient serv-
ice delivery points, and supervise service delivery by other
sectors. The District Health Department (DHD) is part of
the District Health Network and is primarily responsible
for preventive and primary health care services. The DHD
is the most peripheral structural and functional unit of the
District Health System and is responsible for gathering
death data in coordination with the Civil Registration
Organization. Since 1998, a single unified death certifi-
cate is being used, which is legally required to be issued by
a physician for interment. This form is compatible with
the ICD-10 and identifies the immediate, intermediate,
and underlying causes of death for all ages, and four
causes of stillbirths and deaths before the seventh day of
life (maternal immediate, maternal underlying, fetal
immediate, and fetal underlying causes). Since 1998, all
physicians are being trained on how to fill out this form
as a part of their compulsory continued medical educa-
tion. In special cases, death certificates need to be issued
by the Forensic Medicine Organization. DHD uses five
sources of death data for death certificates: (1) district hos-
pital(s), (2) cemeteries, (3) Forensic Medicine Organiza-
tion, (4) service delivery points of DHD, and (5)
complementary sources such as the clergy and voluntary
health workers that become aware of any deaths. Using a
software package specifically designed for this purpose,
data are compiled and checked for duplicate entries at the
district level, sent to the province center on a monthly
basis, and finally processed at the national level for correc-
tion of any residual duplication and redistribution of gar-
bage codes for cause of death. The primary criterion for
registration of death locality is the place of usual resi-
dence. The software does not permit entry of impossible
causes of death (like maternal causes for males) and
prompts for investigation of improbable causes (like
maternal causes in females younger than ten years), by
checking hospital records or verbal autopsy information
[13]. The mechanism for mortality data quality assurance
involves a number of factors and measures. These factors
which are incorporated in the death registration system of
MOHME include: (1) Using multiple sources of data to
minimize missing of deaths, (2) Establishment of a uni-
form death certificate throughout the country, (3) Provi-
sion of the necessary training for the assignment of one
correct cause to a case of death, (4) Provision of training
and guidelines for the assignment of a cause of death to a
disease or injury cause using the ICD list of causes modi-
fied for the epidemiological situation of Iran, and (5) Pre-
venting the assignment of garbage codes to death cases.
The training of physicians on correct completion of death
certificates is crucial for achieving goals 3 to 5 above [13].
The sources of population estimates for the death data sys-
tem for urban areas were the baseline population of the
1996 census, population growth rate resultant from com-
parison of the 1986 and 1996 censuses, and adoption of
the arithmetic progression intercensal method, at the dis-
trict and province levels. In rural areas, annual census con-
ducted by health houses and mobile outreach teams of
the health network provide the population data. Eleven
garbage codes for cause of death were redistributed to the
registered causes in the same age-sex group, within the
same ICD-10 chapter or in other chapters depending on
the nature of the garbage code. For example, "heart fail-
ure" was redistributed among some of the circulatory and
respiratory disease chapters, or "other ill-defined and
unknown causes of mortality" was redistributed among
all causes. Table 1 shows the redistribution methods for
the eleven garbage codes and the relative frequency of
these codes. The proportion of garbage codes in Iran's
death registry was 17%, 20%, and 24% of the total deaths
in 2003, 2002, and 2001 respectively [13]. The two
assumptions, stable population and no migration,
required for the Brass Growth-Balance and Bennett-Hori-
uchi methods of death under-registration correction [1]
did not hold true for Iran's population. Its total fertility
rate dropped from 5.5 in 1990 to 2 in 2003 [15]. We
applied the Bennett-Horiuchi method using the 1996 and
2006 census data, and the resultant values of the Synthetic
Extinct Generation were 1.35 to 1.05 for males between
the ages of 0 and 75, and 1.20 to 1.05 for females in the
same age range. This problem was traced to originate from
the population by age figures from the above-mentioned
censuses. The 0–4 year age group not only had no deaths
during the intercensal years, but also experienced a 550
thousand increase according to census data. Similar prob-
lems were found with other age groups. Instead, we used
death data from the Civil Registration Organization for
estimation of under-registration in MOHME's death regis-
tration system.Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
Page 6 of 21
(page number not for citation purposes)
Morbidity and YLD
For the estimation of disease incidence rates and YLD, epi-
demiological disease modeling was performed for 213
disease and injury causes, mostly using the DISMOD II
software [16]. For a number of disease groups (namely
injuries, perinatal conditions, congenital malformations
and chromosomal abnormalities, maternal conditions,
and neoplasms), epidemiological disease modeling was
performed using modeling templates developed specifi-
cally for this study. Systematic reviews of all sources of
data and epidemiological and clinical studies containing
information on the needed inputs for disease modeling
were conducted in collaboration with clinical medicine
specialists. The following sources of information on the
epidemiology of diseases in Iran were used for epidemio-
logical disease modeling:
Table 1: Redistribution methods for garbage codes of death, Iran 2003
Garbage code




Within each age group above 59 years and in both sexes, redistributed among 5 following 
groups proportional to size of registered deaths: (1) Infectious and parasitic diseases: 
tuberculosis (pulmonary and extrapulmonary), other diarrheal disease, typhoid fever, other 
intestinal infections, viral hepatitis, sexually transmitted diseases, viral hemorrhagic fevers, 
hydatid cyst, anthrax, other infectious and parasitic diseases; (2) Diseases of the blood and 
blood-forming organs and certain disorders involving the immune mechanism: anemias, other 
diseases of blood and blood-forming organs; (3) Unintentional injuries: all causes except 
transport accidents, burns, and drowning; (4) Intentional self-harm: only suicides with 
chemicals, drugs, opium, and homicide; (5) All causes within the following chapters: neoplasms; 
endocrine, nutritional and metabolic diseases; mental and behavioral disorders; diseases of the 
nervous system; diseases of the circulatory system; diseases of the respiratory system; 
diseases of the digestive system; diseases of the skin and subcutaneous tissue; diseases of the 
musculoskeletal system and connective tissue; and diseases of the genitourinary system. Death 
registration software does not permit entry of senility for persons younger than 60 years of 
age.
Unspecified causes of death (4%) (27%) Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for each cause.
Heart failure
(1%) (8%)
Within each age and sex group, redistributed between 2 ICD-10 chapters proportional to size 
of their registered deaths: (1) Some diseases of the circulatory system, and (2) Some diseases 
of the respiratory system.
'Under investigation' (0.7%) (4%) Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for each cause.
Septicemia
(0.5%) (3%)
Within each age and sex group, redistributed among 6 ICD-10 chapters proportional to size of 
their registered deaths: (1) Infectious and parasitic diseases, (2) Some diseases of the digestive 
system, (3) Some of the neoplasms, (4) Some diseases of the respiratory system, (5) Some of 
the conditions originating in the perinatal period, and (6) Some of the causes related to 
pregnancy, childbirth, and the puerperium.
Unspecified neoplasms
(0.5%) (3%)
Within each age and sex group, redistributed among the neoplasms chapter proportional to 
size of registered deaths for each code.
Other ill-defined and unknown causes of mortality
(0.4%) (2%)
Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for each cause.
Mental retardation
(0.2%) (1%)
Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for each cause.
Suspected homicide
(0.2%) (1%)
Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for (1) Unintentional and intentional self-harm, and (2) Assault.
Convulsions (epilepsy excluded)
(0.2%) (1%)
Within each age and sex group, redistributed among registered causes proportional to size of 
registered deaths for each cause.
Sudden Infant Death Syndrome (without autopsy)
(<0.001%) (<1%)
Within the same age group and both sexes, redistributed among all causes proportional to size 
of registered deaths for each code.Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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(1) Disease Surveillance System: The surveillance system
has complete coverage for a number of infectious diseases
such as polio, measles, and Crimean-Congo Hemorrhagic
Fever. For others with incomplete coverage, e.g. HIV,
malaria, and tuberculosis, estimates of surveillance sys-
tem coverage were used to find the actual number of cases.
(2) Cancer Registry: Almost all sites of cancer are covered
by the cancer registry system, which is based primarily on
pathology reports, and therefore does not provide good
coverage for sites that are not routinely biopsied, such as
the central nervous system, lung, and pancreas [17]. Given
the incomplete coverage for some cancer cites, a specific
modeling approach described above was used for mode-
ling cancer dynamics.
(3) Hospital Disease Registries: Hospital registries were
used for diseases that require surgery, such as inguinal her-
nia, cholecystitis, and cholelithiasis. In most provinces,
hospital disease registries for such diseases have near-
complete coverage. The Iranian health services utilization
study of 2002 [18] showed that with an average waiting
time of three days for all inpatient needs, 90% of the cases
where hospitalization was necessary resulted in hospitali-
zation within the same province where the cases origi-
nated, while 10% were moved to a hospital in a different
province. Therefore, a correction factor of 1.11 was used
for data from hospital registries for such diseases. We
added the cases to the provinces of origin and subtracted
them from the provinces they went to.
(4) Representative National Surveys. Most surveys use
structured interviews based on questionnaires, with clini-
cal examination and paraclinical measurements where
necessary, including anthropometric measurements,
Decayed-Missing-Filled teeth, or blood and urine bio-
chemistry. The main diseases in this category were mental
and behavioral diseases including opioid use, malnutri-
tion and micronutrient deficiencies including anemias,
oral conditions, and some of the maternal and perinatal
conditions. The most important surveys were 'Study of
Health and Disease' [19], 'Profile of Population and
Health: Demographic and Health Survey (DHS)' [20],
'Profile of Child Nutrition in Provinces' [21], 'National
Study of Micronutrients' [22], 'Epidemiological Survey of
Psychiatric Disorders in Iran' [23], 'The Epidemiological
Study of Drug Abuse in Iran' [24], and 'Integrated Moni-
toring and Evaluation System for Reproductive Health
Programs' [25].
(5) Subnational and Local Studies, results of which could
be generalized to the national level, e.g. the COPCORD
Study (Community Oriented Program for Control of
Rheumatic Diseases) [26], Isfahan Healthy Heart Study
[27], Persian Gulf Healthy Heart Study [28], Tehran Eye
Study [29], and Epidemiologic Study of Injuries due to
External Causes in Iran [8].
Residual YLD estimation
Since YLLs are calculated for all registered deaths, but
YLDs are not estimated for rare disease and injury causes,
if the residual YLDs are not estimated, the DALY estimates
will be biased towards over-representation of YLL. In com-
parison with the GBD disease list, our more comprehen-
sive list of disease and injury causes already leads to lower
burden left in residual areas. The residual YLD for each
group was estimated using the YLD/YLL ratio for specified
conditions in the group.
Burden estimation at province level
The same methods were used for estimation of YLL, YLD,
and DALY at the province level, using input data from
studies many of which were applicable at the province
level. The 6 selected provinces were the provinces in
which the Health Sector Reform (HSR) projects of
MOHME supported by WHO and the World Bank in Iran
were being implemented as pilot projects, to be extended
to the whole country later. These provinces where chosen
based on their prior capacities for organizational change
in health sector and taking into consideration the fact that
they should represent the provinces with relatively higher
and lower levels of socio-economic and health develop-
ment.
Regional comparisons
Burden of disease estimates from this study were com-
pared with the revised Global Burden of Disease 2002
estimates for the Eastern Mediterranean Region (EMR)
and its sub-region B (EMR-B) [30] for relative magnitude
of DALY rates and rankings of the leading causes of bur-
den.
Results
Detailed tabulations of deaths, YLL, YLD, and DALYs for
the 213 causes included in the IRNBD, classified by GBD
and ICD groups, age, and gender are provided in the Addi-
tional file 1. Below we report the key findings for the bur-
den of disease and injury (DALYs); the mortality burden
due to premature deaths (YLL); and the disability burden
due to non-fatal health outcomes (YLD), along with
regional comparisons, and burden of disease estimates for
six provinces.
(A) Leading causes of DALYs
The burden of disease and injury resulting from prema-
ture deaths and disability was estimated as a total of 14.3
million DALYs in 2003, comprised of 8.8 million years
lived with disability (YLD) and 5.5 million years lost due
to premature death (YLL), or 62% and 38% of total DALYs
respectively. Rates per 100,000 people were 21,572 forPopulation Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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DALYs, 13,271 for YLD, and 8,301 for YLL. Noncommu-
nicable diseases (group II of GBD) caused 58% of the total
number of DALYs, injuries (group III of GBD) caused
28%, and communicable, maternal, perinatal, and nutri-
tional conditions (group I of GBD) caused the remaining
14%. The three disease groups causing the highest DALY
rates in all ages and both sexes were injuries (28% of the
total), mental and behavioral disorders (16%), and circu-
latory system diseases (10%) (see figures 1 and 2). Table
2 shows YLL, YLD, and DALY rates for the three GBD
groups. Table 3 shows the 20 top disease groups with the
highest mortality, YLL, YLD, and DALY rates for all ages
and both sexes.
(B) Sex differentials for leading causes of DALYs
The burden of DALYs was higher for males (53%) than for
females (47%). Sixty-one percent of YLLs and 48% of
YLDs were in males, while 39% of YLLs and 52% of YLDs
were in females. The DALY rate per 1,000 people was
227.1 years for males and 204.0 years for females. YLL
rates were 100.4 year per 1,000 males and 65.3 years per
1,000 females. YLD rates were 126.8 and 138.8 years per
1,000 persons for males and females respectively. The bur-
den of disability was higher in females, while males suf-
fered from a higher burden of premature death, which led
to more burden of disease and death altogether for men as
compared with women (see figure 3). Table 4 shows the
top 20 ICD-10 disease and injury causes with the highest
DALYs by sex for all ages.
The burden of musculoskeletal, genitourinary, endocrine,
nutritional and metabolic diseases, and mental and
behavioral disorders was higher in females, whereas males
had more burden of intentional and unintentional inju-
ries, neoplasms, infectious and parasitic diseases, and
perinatal conditions (in descending order of DALY rates
differences). These differences are important with respect
to primary and secondary prevention approaches. The
burden of disease from road traffic injuries in males was
about five times higher than that in females, from mental
disorders due to opioid use – about ten times higher than
that in females, and from falls – about three times higher
than that in women. The burden of major depressive dis-
order, low back pain, and knee osteoarthritis in females
was about two times higher than the respective burden
levels in males. Naturally, the burden from hemorrhagia
due to fibroids and other causes, and maternal conditions
affected exclusively females. In general, it seems that the
burden due to acute and relatively early consequences of
occupational and social problems fell more on males,
whereas burden due to chronic and late consequences of
occupational, social, and bodily problems affected mainly
females.
Burden of disease groups by DALYs, all ages and both sexes, Iran 2003 Figure 1
Burden of disease groups by DALYs, all ages and both sexes, Iran 2003.
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Top 21 disease and injury causes of ICD-10 with the highest burden, all ages and both sexes, Iran 2003 Figure 2
Top 21 disease and injury causes of ICD-10 with the highest burden, all ages and both sexes, Iran 2003. (1) Nat-
ural disasters: Exposure to forces of nature (including the Bam earthquake of 26 December 2003); (2) Bipolar disorders I, II, 
and cyclothymia; (3) COPD: Chronic Obstructive Pulmonary Disease; (4) Exposure to mechanical forces of the nature; (5) 
Upper Respiratory Infections and otitis media; (6) Respiratory and cardiovascular disorders specific to the perinatal period. 
Note: The rationale for presenting the 21 highest burden of disease and injury causes in this figure is that if the Bam earthquake 
is omitted – since such a huge disaster is not to be repeated every year – still the 20 highest burden disease and injury causes 
are presented.
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Table 2: Diseases with the highest burden; all ages and both sexes, Iran 2003
Measure (per 1,000)
Disease YLL rate YLD rate DALY rate
Disease Value Disease Value Disease Value
Total All diseases 83.0 All diseases 132.7 All diseases 215.7
GBD clusters Injuries (1) 40.1 NCD(2) 95.1 NCD (2) 125.4
NCD (2) 30.3 Injuries (1) 19.6 Injuries (1) 59.7
C.M.P.N. (3) 12.7 C.M.P.N. (3) 17.9 C.M.P.N. (3) 30.6
(1) Group III of GBD; (2) NCD: Noncommunicable Diseases (group II of GBD); (3) C.M.P.N.: Communicable, Maternal, Perinatal, and Nutritional 
conditions (group I of GBD)Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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There was an extra burden of disability in females between
the ages of 15–69, as compared with males, especially in
the 40–65 year range. On the other hand, an extra burden
of death affected males between the ages of 5 and 69, in
comparison with females, especially in the 20–64 age
groups (see figure 3). The DALY rates values against age
resembled a check mark, with the lowest values at age 5–
14, returning to at-birth values at age 60–69, and the high-
est values at the highest age of 80 or older. Females had
lower DALY rates than males in all age groups, except in
the 45–64 one.
(C) Burden by disease type and age
Injuries (group III of GBD) caused the highest proportion
of mortality burden in the 5–44 year age group, and non-
communicable diseases were the leading cause of this bur-
den in the population older than 44 years, for both sexes.
Noncommunicable diseases were the leading cause of dis-
ability burden in the 15–69 year age group, particularly
mental disorders such as opioid use and major depressive
disorder; cardiovascular diseases such as ischemic heart
disease and cerebrovascular disease; musculoskeletal dis-
eases such as knee arthritis and low back pain; genitouri-
nary diseases in women, such as fibroids and
consequences of menopause, and other diseases such as
anemia, skin disease, and diabetes mellitus. Injuries
caused the highest proportion of YLD in the population
older than 80 years, most notably due to falls, and often
aggravated by osteoporosis. Perinatal conditions caused
the most disability burden (YLD) in the 0–4 year age
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(1) Natural disasters (exposure to forces of nature) including the Bam earthquake of 26 December 2003; (2) Major depressive disorder; (3) Mental 
and behavioral disorders due to use of opioids or opioids with multiple drugs; (4) Respiratory and cardiovascular disorders specific to the perinatal 
period; (5) COPD: Chronic obstructive Pulmonary DiseasePopulation Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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group. Noncommunicable diseases were the leading
cause of the total burden of mortality and disability
(DALYs) in the population older than 15. The Injuries
group was responsible for the highest total burden in the
5–14 year age group, and perinatal conditions, malnutri-
tion and its consequences such as iron deficiency anemia
caused the highest total burden in the 0–4 year age group.
The burden is measured by DALY rates per 100,000, and
proportions of the absolute number of years lost among
age groups are not the same (see figures 4, 5 and 6).
Appendix table S2 shows the top eleven disease and injury
causes with the highest DALY rates by age groups in both
sexes [see Additional file 2].
(D) Burden of disease estimation for six provinces of Iran
YLL and YLD for six provinces of Iran were calculated for
different age groups and both sexes; these estimates were
based on epidemiological estimates at the province level
in many cases. Comparison of the findings with national
results showed that intentional and unintentional injuries
had the highest DALY rates in all six provinces, which
resembled the picture at the national level. In a similar
way, mental and behavioral disorders had the second
highest DALY rates in the selected six provinces. The dif-
ferences among the provinces as well as with the national
average burden started from the disease with the third
highest DALY rates, based on different socioeconomic
determinants and epidemiological settings (see figure 7).
Table 5 shows the order of disease groups by DALYs in
these six provinces.
(E) Regional comparisons
The total burden of disease (DALY rate per 100,000) in
Iran in 2003 was higher than the WHO estimate of burden
in EMR-B in 2002 and lower than that in EMR in 2002
(see figure 8). The burden of communicable, maternal,
perinatal, and nutritional conditions (as a group) was
lower in Iran than in EMR and EMR-B, and the burden of
injuries was higher in Iran than in these regions (see figure
9). Within the former group, communicable diseases and
maternal conditions had much lower burden in Iran than
in both EMR-B and EMR. The burden of noncommunica-
ble diseases in Iran was lower than that in EMR but higher
than that in EMR-B. The burden due to perinatal and
nutritional conditions in Iran was higher than that in
EMR-B and lower than the burden due to these causes in
EMR. While the burden of cardiovascular disease was rel-
atively similar in Iran, EMR and EMR-B, the burden of
neuropsychiatric disorders was higher in Iran, mainly due
to the burden of major depressive disorder and mental
disorders due to opioid use. Excess burden of major
depressive disorder was observed mainly among the mid-
Sex differentials in burden of disease by age, Iran 2003 Figure 3
Sex differentials in burden of disease by age, Iran 2003. The orange shaded area under the YLD curve for females 
between ages 15–69 shows the extra burden of disability for this group. The blue shaded area under the YLL curve for males 
between ages 5–69 shows the extra burden of mortality in this group.Population Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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dle-aged females and extra burden of mental disorders
due to opioid use – among middle-aged males. The bur-
den of both unintentional and intentional injuries was
nearly two times higher in Iran than in EMR-B and EMR,
mainly due to the higher burden of injuries in Iranian
males. The major part of this higher burden was observed
in young and middle-aged Iranian males as victims of
road traffic injuries (see figure 10).
Discussion
(A) Health transition
The most prominent finding of the first national burden
of disease study in Iran for 2003, as indicated by the mix
and levels (rates) of YLD, YLL, and DALYs caused by three
groups of noncommunicable diseases, injuries, and "com-
municable, maternal, perinatal, and nutritional condi-
tions," was an advanced health transition profile from
communicable, maternal, and perinatal conditions and
nutritional deficiencies, through injuries, to the domi-
Table 4: Top 20 disease and injury causes with the highest DALYs by sex, all ages, Iran 2003
Males DALY Females DALY
Road traffic injuries 1070969 Ischemic heart disease 437709
Natural disasters (1) 548299 Major depressive disorder 420475
Opioid use (2) 510291 Natural disasters (1) 419781
Ischemic heart diseases 433627 Road traffic injuries 234745
Falls 274038 Cerebrovascular disease 206869
Exposure to mechanical forces 202494 Low back pain 199896
Major depressive disorder 181101 Knee osteoarthritis 196343
Cerebrovascular disease 146770 Anemias 165411
Bipolar disorders 139501 Bipolar disorders 128402
COPD (3) 128230 Burns 105194
Burns 114677 COPD (3) 104381
Low back pain 107876 Panic disorder 100129
Anemias 104169 Diabetes Mellitus 99670
Calculus of kidney and ureter 95688 Falls 90206
Knee osteoarthritis 94962 Obsessive-compulsive disorder 88449
Premature birth with normal weight 93740 Schizophrenia and schizo-affective disorders 82582
Perinatal respiratory and cardiovascular disorders (4) 84779 Menopause (hot flushes & atrophic vaginitis) 76314
Intentional self-harm 84424 Acne vulgaris 75689
Premature birth with low weight 78850 Upper respiratory infections and otitis media 74009
Assault 76797 Premature birth with normal weight 73102
(1) Natural disasters (exposure to forces of nature) including the Bam earthquake of 26 December 2003; (2) Mental and behavioral disorders due 
to use of opioids or opioids with multiple drugs; (3) COPD: Chronic Obstructive Pulmonary Disease; (4) Respiratory and cardiovascular disorders 
specific to the perinatal periodPopulation Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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nance of noncommunicable diseases in the overall picture
of disease burden. Assessment of mortality and morbidity
rates had demonstrated the dominance of noncommuni-
cable, maternal, perinatal, and nutritional conditions in
Iran in recent four decades, as well as the start of the
health transition in the past few years [31-33]. While this
was the prominent overall national picture, results at the
province level showed the variability of health transition
advancement among provinces, which can be due to dif-
ferences in the relative socioeconomic development levels
of the studied provinces. Whereas the overall dominance
of injuries and noncommunicable diseases was observed
for the top three most burdensome disease groups in all
six provinces, the Hormozgan province was an exception
to this; there infectious and parasitic diseases (including
malaria) caused the third highest burden. Maternity-
related disease burden ranked last, due to the advances in
the reduction of maternal mortality, but the burden of
perinatal conditions was much higher, mainly due to the
difficulties in reducing neonatal disease burden.
(B) Implications for health policies and programs
The mix of causes for YLL and YLD shows reducing the
burden of which disease groups can extend the total life
expectancy (relatively more than increasing the healthy
life expectancy), and proper management of which other
disease groups is expected to have a larger effect on reduc-
ing disability and increasing the healthy life expectancy
(as compared with the resultant increase in total life
span). Hence, by decreasing the perinatal mortality and
the frequency and intensity of road traffic injuries, the
total life expectancy can be improved (with relatively less
increase in healthy life expectancy), since these disease
and injury causes have very high YLL to YLD ratios. On the
other hand, through reducing the incidence of and
increasing the quality of healthcare for noncommunica-
ble diseases such as ischemic heart disease, major depres-
sive disorder, and mental disorders due to opioid use, loss
of healthy years of life can be prevented, and the relative
gain in healthy life expectancy should be higher than the
relative increase in total life expectancy. Across the age-
and sex-specific subgroups, as well as in different geo-
graphical regions, the priority areas for intervention differ,
a matter of crucial importance for customizing the priority
diseases' control projects over person and place variables.
The use of results in priority setting is discussed below.
(C) Comparison of Iran's National Burden of Disease study 
with international estimates and their differences
We compared our study results with WHO estimates for
subregion B of Eastern Mediterranean Region (EMR-B) for
year 2002 since the latter set of burden estimates had the
nearest reference year of calculations to our own reference
year and Iran is located in this subregion of EMR. Details
of comparisons for DALY, YLL, and YLD at cause groups
and specific cause levels are provided in Additional File 3.
Share of YLL by three GBD disease groups and age, Iran 2003 Figure 4
Share of YLL by three GBD disease groups and age, Iran 2003. Figures in black indicate the percent of YLL due to inju-
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Some differences exist between Iran's NBD and WHO esti-
mates for EMR-B, the most important ones of which are
described below along with the most possible reasons for
the differences.
C1: YLL
Estimate of all-cause YLL rate in 100000 population in
our study is higher than WHO's estimate for EMR-B. The
main reason for this difference is inclusion of about
30000 deaths from Bam earthquake of December 2003 in
our study. If the YLD due to Bam earthquake not included,
our all-cause YLL would in fact be even slightly lower than
estimate for EMR-B by WHO.
C2: YLD
YLD rate estimate in our study is higher than that by WHO
for EMR-B for all-cause and all-ages and for some of the
causes and over most age groups. These differences should
be due to the following facts.
a. We omitted 18 causes form the GBD cause list (9 causes
in cluster I, 8 causes in cluster II, and one cause in cluster
III), which are not existent in Iran or are in elimination
and eradication phase, or there was not any information
or study available about their prevalence estimates in Iran.
On the other hand, we added 92 causes to the GBD cause
list, as described above under 'Choosing the diseases' in
Methods section. Therefore, strict comparisons of YLL and
YLD for and at all-cause, cluster, or disease group levels
would not reach rational results. Moreover, addition of
the above-mentioned causes changes the age and sex dis-
tribution of YLD rates within clusters, since the added
causes are mainly of high YLD and more incident among
women. Table S8 in Additional File 3 shows these dis-
eases.
b. For all causes present in GBD cause list, we used the dis-
ability weights from GBD study directly without adjusting
for differences in case-fatality in Iran. For causes not
present in GBD cause list, disability weights were taken
from Dutch Disability Weights Group [11] or reproduced
as described under 'Disability weights' in Methods sec-
tion. Similarly, the same disease or disability durations
were used from GBD study method, unless for the causes
whose GBD duration values were inconsistent with the
actual duration times in Iran. For such causes, duration
was estimated using Iranian clinical specialists and disease
epidemiology experts' views and studies. The important
point is the differences in proportion of patients who had
access to treatment and utilized the services, and in effec-
tiveness of such treatments in terms of reducing the disa-
bility duration, that existed for some causes between the
actual circumstances in Iran and those circumstances lead-
ing to GBD disability duration estimates. Where such dif-
ferences became evident according to available evidence
from studies and expert views in Iran, disease duration
Share of YLD by three GBD disease groups and age, Iran 2003 Figure 5
Share of YLD by three GBD disease groups and age, Iran 2003. Figures in blue indicate the percent of YLD due to 
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estimates based on local evidence were used instead of
GBD duration estimates. Prominent examples include
effective treatment coverage for cancers, ischemic heart
diseases, and injuries, especially falls with femoral neck
fractures among the elderly. For duration estimation of
cancers, we used survival data from Iran and for ischemic
heart diseases, and injuries we forced the estimated dura-
tions into DISMOD.
c. Part of the differences in YLD between our results and
WHO estimates are due to differences in age distribution
of some disease frequencies. Many studies existed in Iran
that revealed the age patterns of disease frequencies in
Iran which were different from those used for WHO esti-
mates and these studies' results were used in our estima-
tions. Examples include iron deficiency anemia, drug use
disorders, bipolar disorders, and road traffic injuries.
d. There are clear differences in YLD rate estimates for
some of the causes in GBD list between the present study
and WHO estimates, whose possible reasons are
described below.
- Drug use disorders
In Iran, these causes mainly included addiction to opium,
heroin, opium-derivative containing medicines, and tran-
quilizer medicines. Prevalence rate estimates for these dis-
orders were taken from Epidemiologic Study of Drug
Abuse in Iran for year 2001 [24]. Incidence estimates for
males and males were 4.7 and 0.75 in 1000 respectively
(with different age distributions). Cause-specific mortality
rate estimates were 0.07 and 0.003 in 1000 for males and
females respectively. Proportion of treated patients was
less than 0.2 in 2003 and disease duration surpassed 3
years. Disability weight was the same as that in GBD
indeed. The above-mentioned study showed that based
on DSM-IV definitions, 1.5 million opium addicts, 120
thousand heroin addicts, and 5 million opium abusers
(irregular and non-dependent abusers) existed in Iran in
2001 [24]. Only the two former figures (opium and her-
oin addicts) were included for burden estimation in this
study. The observed difference in YLD estimates for drug
abuse disorders between our estimates and WHO esti-
mates for EMR-B is only due to our higher incidence rate
and difference in its age distribution and lengthier disease
duration.
Share of DALYs by three GBD disease groups, Iran 2003 Figure 6
Share of DALYs by three GBD disease groups, Iran 2003. Figures in blue indicate the percent of DALYs due to non-
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- Road traffic injuries (RTI)
WHO's GBD study for year 2002 showed that Iran had the
highest mortality rate from road traffic accidents and
ranked third among all countries for its DALYs. Therefore,
Iran's estimates for RTI burden are naturally much higher
than those for the EMR-B subregion.
- Falls
Our study estimates for YLD from falls among the elderly
were much higher than WHO estimates for EMR-B, a dif-
ference which is principally due to higher incidence of
falls with femoral neck fracture in Iranian elder popula-
tion, according to a study on epidemiology of injuries due
to external causes in Iran [8], limited access to appropriate
treatment for femoral neck fracture, and the resultant
elongated duration of disability ensuing from the fracture.
Therefore, the higher incidence rates and disability dura-
tion as compared with WHO study are the reasons for the
observed differences.
- Low back pain
This cause included cervical arthrosis and pain, high back
pain, and lumbar pain with or without sciatica in our
study. Prevalence rate estimates were taken from COP-
CORD study in Iran [26]. For cervical and lumbar pains
without radiation to extremities, mean duration was 14
days with 85% remission and 42 days with 100% remis-
sion. For lumbar pain with sciatica, mean duration was 28
days with 85% remission and 42 days with 100% remis-
sion. Differences between our study and WHO's are due to
different disease definitions and age and sex specific inci-
dence rates.
- Osteoarthritis
Based on available pertinent studies in Iran, we estimated
the YLD for unilateral and bilateral knee osteoarthritis,
and other types of unilateral and bilateral osteoarthritis
(pelvic, etc.) were not included. Mortality and definitive
remission were not considered for knee osteoarthritis, but
only flare-up and remission periods were taken into calcu-
lations. Disability weight for bilateral knee osteoarthritis
does not exist in GBD and hence it was reproduced for our
study. The observed differences between our estimates
and those by WHO are due to lack of access to effective
treatment, differences in disability durations, and addi-
tion of bilateral form of disease into burden estimation in
Iran.
- Ischemic heart disease
Three distinct forms were included in our study based on
the available information sources. (1) Acute myocardial
infarction and imminent death before access to hospital:
This subgroup of patients with acute myocardial infarc-
tion died without access to hospital, before reaching to
Total YLD and YLL rates per 100,000 in six provinces of Iran in 2003 Figure 7
Total YLD and YLL rates per 100,000 in six provinces of Iran in 2003.
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hospital, and before receiving effective life-saving treat-
ments within hospitals in Iran: 9% of males and 17% of
females in 30–44 year age group, 8% of males and 16% of
females in 45–59 year, 2% of males and 3% of females in
60–69 year, 13% of males and 20 of females in 70–79
year, and 43% of males and 58% of females in 80 year and
above [27,28]. YLL but not YLD was estimated for this
subgroup, since mean disease duration from infarction to
death was estimated as only 6 hours. (2) Angina pectoris:
No mortality was regarded for this group while they had
angina only. Disease duration before exiting this disease
and entering other diseases or remission was different
across age groups. Mean duration for all ages and both
sexes was 3.5 years. Disability weight was the same as
GBD's.  (3)  Acute myocardial infarction patients who
found access to hospital admission and treatment, finally
remitted and were discharged from hospital after 24 days
(80%), died after 3 months (15%), or entered heart fail-
ure (5%). The latter group died after 3 months (5%) or
entered a compensated heart failure status (95%), with a
mean duration of 6 years [27,28]. Disability weights for
myocardial infarction and heart failure were the same as
GBD weights. Differences between our estimates and
WHO's are due to differences in incidence rates, their age
patterns, and disability durations based on different mix
of access to effective treatment services.
- Panic disorders
Prevalence and incidence rates were adopted from a large
national survey for psychiatric disorders [23]. Difference
in age pattern of incidence is the main cause of difference
of YLD due to panic disorder between our study and
WHO estimates, as shown in figure S12 of the Additional
File 3. Disability weight was the same as GBD's and no
mortality was included.
e. From group of diseases included in Iran's study but not
in WHO estimates, two examples with clinically observa-
ble YLD ample.
- Acne vulgaris
Incidence rate estimate for both sexes was 11% in 15–29
year age group and 2% in 30–45 year. Duration was 2.5
and 1.7 years for these two age groups respectively, with-
out any mortality. Disability weight was equal with that
for eczema from Dutch Disability Weights Group [11], or
0.056.
Table 5: Top 11 disease groups with the highest burden (DALY rates/100,000) in six provinces, all ages and both sexes, Iran 2003
Provinces and disease groups
Rank National level East Azerbaijan Bushehr Charmahal Bakhtiary Hormozgan Khorasan Yazd
1 Injuries Injuries Injuries Injuries Injuries Injuries Injuries
2M e n t a l   (1) Mental (1) Mental (1) Mental (1) Mental (1) Mental (1) Mental (1)
3 Circulatory Circulatory Circulatory Circulatory Infectious Circulatory Circulatory
4 Perinatal Musc.-skel. (2) Congenital (3) Musc.-skel. (2) Circulatory Musc.-skel. (2) Musc.-skel. (2)
5 Musc.-skel. (2) Respiratory Perinatal Perinatal Perinatal Perinatal Respiratory
6 Genitourin. (4) Genitourin. (4) Musc.-skel. (2) Genitourin. (4) Blood system(5) Genitourin. (4) Endocrine (6)
7 Digestive Neoplasms Genitourin. (4) Digestive Respiratory Digestive Genitourin. (4)
8 Respiratory Digestive Digestive Respiratory Musc.-skel. (2) Respiratory Perinatal
9 Endocrine (6) Perinatal Endocrine (6) Skin (7) Digestive Infectious Neoplasms
10 Neoplasms Endocrine (6) Neoplasms Neoplasms Congenital (3) Neoplasms Digestive
11 Nervous (8) Infectious Nervous (8) Endocrine (6) Genitourin. (4) Endocrine (6) Nervous (8)
(1) Mental and behavioral disorders; (2) Musculoskeletal diseases; (3) Congenital malformations and chromosomal abnormalities; (4) Genitourinary 
diseases; (5) Blood and blood forming organs diseases; (6) Endocrine, nutritional and metabolic diseases; (7) Skin and subcutaneous tissues diseases; 
(8) Nervous system diseasesPopulation Health Metrics 2009, 7:9 http://www.pophealthmetrics.com/content/7/1/9
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- Menopause
For this period of female life that is accompanied with
pathophysiologic consequences in most cases, two dis-
tinct conditions were included in YLD estimation sepa-
rately and their sum of YLD accounted as YLD due to
menopause. These two conditions were menopausal cli-
macteric states (symptoms such as flushing, sleeplessness,
headache, lack of concentration) with ICD code N59.1
and postmenopausal atrophic vaginitis with ICD code
N59.2. Incidence rates were estimated as 7.8% and 2.9%
respectively for N59.1 and N59.2 among the females of
45–59 year age. Disability duration was estimated as
equal to two years for the two conditions consecutively
(not as separate episodes) based on clinical specialists'
opinion. Disability weights were estimated as 0.1 for
N95.1 and 0.03 for N95.2 based on simulation with sim-
ilar conditions by the clinicians' opinion.
(D) Study limitations and innovations
Epidemiological estimations of disease status transition
rates used as inputs for disease modeling are generally
based on more extensive and accurate information in
developed countries, as compared with those in develop-
ing countries, due to the less developed disease surveil-
lance, death registry, and biomedical and health research
policies and practices in the latter group. Nevertheless, we
reviewed all the available published and unpublished
information needed for epidemiological disease mode-
ling in Iran. Some information came from studies with
subnational coverage, and assumptions were made about
their generalizability to the national population. We also
used a modeling approach for estimation of the total pop-
ulation and its subgroups, based on extrapolations of the
most recent intercensal period. It is not expected that
rankings of the disease groups (by GBD groups or major
disease groups) or even ranks of the most burdensome
detailed causes within each disease group are very sensi-
tive to these assumptions. Lack of full coverage for death
data of the 5 out of 28 provinces in 2003 did not affect
much the estimations of mortality and YLL rates and did
not affect the ranking of the cause groups by YLL or
DALYs, because the values of these rates for the 23 prov-
inces were not very different from those for the 28 prov-
inces, the latter obtained later as described below.
Mortality and YLL rates for the 23 provinces in 2003 were
438 and 6,412 per 100,000 respectively (without taking
into account the Bam earthquake). Mortality data for four
out of the five provinces that were not fully covered by the
death registration system in 2003 was obtained in 2004.
Mortality and YLL rates for all provinces of Iran, except the
Tehran province, were 451 and 6,661 per 100,000 respec-
tively in 2004, and 434 and 6,269 in 2005 [34,35].
Besides these six mentioned values for mortality and YLL
rates, all other rates are estimated and presented taking the
Bam earthquake into account. We used disability dura-
tions for disease and injuries mainly from GBD study
Total DALY rates per 100,000 by sex, all ages, Iran 2003, EMR Sub-region B (EMRB) 2002, and Eastern Mediterranean Region  (EMR) 2002 Figure 8
Total DALY rates per 100,000 by sex, all ages, Iran 2003, EMR Sub-region B (EMRB) 2002, and Eastern Medi-
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DALY rates per 100,000, by three disease groups of GBD, all ages and both sexes, Iran 2003, EMR Sub-region B (EMRB) 2002,  and Eastern Mediterranean Region (EMR) 2002 Figure 9
DALY rates per 100,000, by three disease groups of GBD, all ages and both sexes, Iran 2003, EMR Sub-region 
B (EMRB) 2002, and Eastern Mediterranean Region (EMR) 2002. C.M.P.N.: Communicable, Maternal, Perinatal, and 
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DALY rates per 100,000 from road traffic injuries by sex, all ages, Iran 2003, EMR Sub-region B (EMRB) 2002, and Eastern Med- iterranean Region (EMR) 2002 Figure 10
DALY rates per 100,000 from road traffic injuries by sex, all ages, Iran 2003, EMR Sub-region B (EMRB) 2002, 
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method, except for cancers, ischemic heart diseases, and
injuries.
Adaptations of the methods recommended by WHO for
the National Burden of Disease studies were made, some
of which could be considered innovative and value-add-
ing. The burden of disease was estimated at the subna-
tional level, although only in six provinces.
Conclusion
The health and disease profile in Iran has made the tran-
sition from the dominance of communicable diseases to
that of noncommunicable diseases and injuries. NBD
results are to be used in health program planning,
research, and resource generation policies and practices.
(A) Use of the current study's results
Burden of disease results provide a crucial part of biomed-
ical information needed for evidence-based health policy-
making. This information along with economic analyses
of the cost-effectiveness of interventions forms a strong
platform for the advancement of evidence use in health
policy and management. In essence, the diseases, injuries,
and risk factors causing the highest burden should be
assessed with respect to the current evidence, its accuracy
and national applicability, on the effectiveness and cost-
effectiveness of available prevention and control interven-
tions, and the availability of organizational, human,
financial, and technological resources. The NBD results
can provide strategic directions for population health
research, resource generation and expansion, health pro-
grams evaluation, health system development, and future
forecasting. This opportunity can be viewed and used as a
substantial advancement in evidence-based health policy-
making and program planning.
(B) Future rounds of Iran's NBD study
The NBD study is to be conducted every five years, in
order to coincide with the five-year cycle of the Compre-
hensive Social and Economic Development Master Plan
of I. R. Iran. The second IRNBD study is being launched to
make 2005 estimates.
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